Compare CDNA & COTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CDNA | COTY |
|---|---|---|
| Founded | 1998 | 1904 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.1B |
| IPO Year | 2007 | 2012 |
| Metric | CDNA | COTY |
|---|---|---|
| Price | $64.58 | $3.22 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 7 | 17 |
| Target Price | ★ $61.67 | $2.66 |
| AVG Volume (30 Days) | 1.4M | ★ 4.8M |
| Earning Date | 10-29-2026 | 11-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | $48,324,000.00 | ★ $5,806,600,000.00 |
| Revenue This Year | $30.36 | N/A |
| Revenue Next Year | $6.23 | N/A |
| P/E Ratio | $31.29 | ★ N/A |
| Revenue Growth | ★ 18.93 | N/A |
| 52 Week Low | $14.03 | $1.82 |
| 52 Week High | $72.51 | $4.34 |
| Indicator | CDNA | COTY |
|---|---|---|
| Relative Strength Index (RSI) | 57.22 | 75.38 |
| Support Level | $61.19 | $3.03 |
| Resistance Level | $72.51 | $3.44 |
| Average True Range (ATR) | 3.98 | 0.11 |
| MACD | -0.48 | 0.06 |
| Stochastic Oscillator | 25.72 | 91.55 |
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
Coty is a global beauty maker that generates 65% of sales from prestige beauty products (primarily fragrances) and 35% from mass makeup, skin care, and fragrance. For the fragrance business, Coty licenses luxury and high-end brands including Gucci, Burberry, Hugo Boss, Davidoff, and Calvin Klein. In contrast, its consumer cosmetics business focuses on acquired mass brands such as CoverGirl, Max Factor, Rimmel, Sally Hansen, and Bourjois. It also collaborates with social media celebrity Kylie Jenner to manage makeup products bearing her name. By region, Coty generates close to 48% of sales from Europe, 40% from the Americas, and 12% from Asia-Pacific. German investment firm JAB is a controlling shareholder, with a 54% stake.